References:
1. Confavreux C, Vukusic S (2006) Accumulation of irreversible disability in multiple sclerosis: from epidemiology to treatment. Clinical neurology and neurosurgery 108 (3):327-332. doi:10.1016/j.clineuro.2005.11.018
2. Herrmann MM, Barth S, Greve B, Schumann KM, Bartels A, Weissert R (2016) Identification of gene expression patterns crucially involved in experimental autoimmune encephalomyelitis and multiple sclerosis. Disease models & mechanisms 9 (10):1211-1220. doi:10.1242/dmm.025536
3. Vartzelis G, Maritsi D, Nikolaidou M, Garoufi A, Kilidireas C (2019) Rituximab as Rescue Therapy for Aggressive Pediatric Multiple Sclerosis. Case reports in pediatrics 2019:8731613. doi:10.1155/2019/8731613
4. Kucukali CI, Kurtuncu M, Coban A, Cebi M, Tuzun E (2015) Epigenetics of multiple sclerosis: an updated review. Neuromolecular medicine 17 (2):83-96. doi:10.1007/s12017-014-8298-6
5. Chu F, Shi M, Lang Y, Shen D, Jin T, Zhu J, Cui L (2018) Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives. Mediators of inflammation 2018:8168717. doi:10.1155/2018/8168717
6. Waubant E, Lucas R, Mowry E, Graves J, Olsson T, Alfredsson L, Langer-Gould A (2019) Environmental and genetic risk factors for MS: an integrated review. Annals of clinical and translational neurology 6 (9):1905-1922. doi:10.1002/acn3.50862
7. Rawji KS, Yong VW (2013) The benefits and detriments of macrophages/microglia in models of multiple sclerosis. Clinical & developmental immunology 2013:948976. doi:10.1155/2013/948976
8. Aguzzi A, Barres BA, Bennett ML (2013) Microglia: scapegoat, saboteur, or something else? Science 339 (6116):156-161. doi:10.1126/science.1227901
9. Vogel DY, Vereyken EJ, Glim JE, Heijnen PD, Moeton M, van der Valk P, Amor S, Teunissen CE, van Horssen J, Dijkstra CD (2013) Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation 10:35. doi:10.1186/1742-2094-10-35
10. Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. The Journal of clinical investigation 122 (3):787-795. doi:10.1172/JCI59643
11. Mantovani A, Sica A, Locati M (2005) Macrophage polarization comes of age. Immunity 23 (4):344-346. doi:10.1016/j.immuni.2005.10.001
12. Mikita J, Dubourdieu-Cassagno N, Deloire MS, Vekris A, Biran M, Raffard G, Brochet B, Canron MH, Franconi JM, Boiziau C, Petry KG (2011) Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Multiple sclerosis 17 (1):2-15. doi:10.1177/1352458510379243
13. Zhang XM, Lund H, Mia S, Parsa R, Harris RA (2014) Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice. Glia 62 (5):804-817. doi:10.1002/glia.22643
14. Kobashi S, Terashima T, Katagi M, Nakae Y, Okano J, Suzuki Y, Urushitani M, Kojima H (2019) Transplantation of M2-Deviated Microglia Promotes Recovery of Motor Function after Spinal Cord Injury in Mice. Molecular therapy : the journal of the American Society of Gene Therapy. doi:10.1016/j.ymthe.2019.09.004
15. Blackwell TS, Christman JW (1997) The Role of Nuclear Factor- κ B in Cytokine Gene Regulation. Am J Respir Cell Mol Biol 17 (1):3-9
16. Liu ZG, Hsu H, Goeddel DV, Karin M (1996) Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death. Cell 87 (3):565-576
17. Denk A, Wirth T, Baumann B (2000) NF-kappaB transcription factors: critical regulators of hematopoiesis and neuronal survival. Cytokine & Growth Factor Reviews 11 (4):303-320
18. Pahan K, Schmid M (2000) Activation of nuclear factor-kB in the spinal cord of experimental allergic encephalomyelitis. Neuroscience Letters 287 (1):17-20
19. Mori N, Yamada Y, Ikeda S, Yamasaki Y, Tsukasaki K, Tanaka Y, Tomonaga M, Yamamoto N, Fujii M (2002) Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 100 (5):1828-1834. doi:10.1182/blood-2002-01-0151
20. Xie Z, Chen J, Zheng C, Wu J, Cheng Y, Zhu S, Lin C, Cao Q, Zhu J, Jin T (2017) 1,25-dihydroxyvitamin D3 -induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells. Immunology 152 (3):414-424. doi:10.1111/imm.12776
21. Huang WJ, Chen WW, Zhang X (2017) Multiple sclerosis: Pathology, diagnosis and treatments. Experimental and therapeutic medicine 13 (6):3163-3166. doi:10.3892/etm.2017.4410
22. Banerjee S, Cui H, Xie N, Tan Z, Yang S, Icyuz M, Thannickal VJ, Abraham E, Liu G (2013) miR-125a-5p regulates differential activation of macrophages and inflammation. The Journal of biological chemistry 288 (49):35428-35436. doi:10.1074/jbc.M112.426866
23. Malyshev I, Malyshev Y (2015) Current Concept and Update of the Macrophage Plasticity Concept: Intracellular Mechanisms of Reprogramming and M3 Macrophage ”Switch” Phenotype. BioMed research international 2015:341308. doi:10.1155/2015/341308
24. Almolda B, Gonzalez B, Castellano B (2011) Antigen presentation in EAE: role of microglia, macrophages and dendritic cells. Frontiers in bioscience 16:1157-1171
25. Jiang HR, Milovanovic M, Allan D, Niedbala W, Besnard AG, Fukada SY, Alves-Filho JC, Togbe D, Goodyear CS, Linington C, Xu D, Lukic ML, Liew FY (2012) IL-33 attenuates EAE by suppressing IL-17 and IFN-gamma production and inducing alternatively activated macrophages. European journal of immunology 42 (7):1804-1814. doi:10.1002/eji.201141947
26. Liu C, Li Y, Yu J, Feng L, Hou S, Liu Y, Guo M, Xie Y, Meng J, Zhang H, Xiao B, Ma C (2013) Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil. PloS one 8 (2):e54841. doi:10.1371/journal.pone.0054841
27. Poggi A, Zocchi MR, Costa P, Ferrero E, Borsellino G, Placido R, Galgani S, Salvetti M, Gasperini C, Ristori G (1999) IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients. Journal of immunology 162 (7):4349-4354
28. Airas L (2015) Hormonal and gender-related immune changes in multiple sclerosis. Acta neurologica Scandinavica 132 (199):62-70. doi:10.1111/ane.12433
29. Blonda M, Amoruso A, Grasso R, Di Francescantonio V, Avolio C (2017) Multiple Sclerosis Treatments Affect Monocyte-Derived Microvesicle Production. Frontiers in neurology 8:422. doi:10.3389/fneur.2017.00422
30. Luo C, Jian C, Liao Y, Huang Q, Wu Y, Liu X, Zou D, Wu Y (2017) The role of microglia in multiple sclerosis. Neuropsychiatric disease and treatment 13:1661-1667. doi:10.2147/NDT.S140634
31. Subramaniam SR, Federoff HJ (2017) Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease. Frontiers in aging neuroscience 9:176. doi:10.3389/fnagi.2017.00176
32. Vogel DYS (2015-02-20) Macrophage Microglia Plasticity in Multiple Sclerosis.
33. Parsa R, Andresen P, Gillett A, Mia S, Zhang XM, Mayans S, Holmberg D, Harris RA (2012) Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice. Diabetes 61 (11):2881-2892. doi:10.2337/db11-1635
34. Wang Y, Wang YP, Zheng G, Lee VW, Ouyang L, Chang DH, Mahajan D, Coombs J, Wang YM, Alexander SI, Harris DC (2007) Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney international 72 (3):290-299. doi:10.1038/sj.ki.5002275
35. Hilliard B, Samoilova EB, Liu TS, Rostami A, Chen Y (1999) Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells. Journal of immunology 163 (5):2937-2943
36. Qin H, Wilson CA, Lee SJ, Zhao X, Benveniste EN (2005) LPS induces CD40 gene expression through the activation of NF-κB and STAT-1α in macrophages and microglia. Blood 106 (9):3114-3122. doi:10.1182/blood-2005-02-0759
37. Zhang XM, Zheng XY, Sharkawi SS, Ruan Y, Amir N, Azimullah S, Hasan MY, Zhu J, Adem A (2013) Possible protecting role of TNF-alpha in kainic acid-induced neurotoxicity via down-regulation of NFkappaB signaling pathway. Curr Alzheimer Res 10 (6):660-669. doi:10.2174/15672050113109990007